Evidence map›Paper›PMID 30934855›Full record

ArticlePathogens (Basel, Switzerland)2019

Epidemiology of Tick-Borne Encephalitis (TBE) in Germany, 2001⁻2018.

Wiebke Hellenbrand, Teresa Kreusch, Merle M Böhmer, Christiane Wagner-Wiening, Gerhard Dobler, Ole Wichmann, Doris Altmann

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. [Health and climate change-what is the potential of real-world data?]Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2024
    Review
  14. Article
  15. Article
  16. Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wiebke HellenbrandImmunization Unit, Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany. HellenbrandW@rki.de.ORCID 0000-0002-8563-3629
Teresa KreuschImmunization Unit, Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany. KreuschT@rki.de.
Merle M BöhmerDepartment for Infectious Disease Epidemiology, Bavarian Health and Food Safety Authority, Veterinaerstr. 2, 85764 Oberschleissheim, Germany. Merle.Boehmer@lgl.bayern.de.
Christiane Wagner-WieningState Health Office Baden-Wuerttemberg, Nordbahnhofstr. 135, 70191 Stuttgart, Germany. Christiane.Wagner-Wiening@rps.bwl.de.
Gerhard DoblerBundeswehr Institute of Microbiology, Neuherbergstrasse 11, 80937 Munich, Germany. gerharddobler@bundeswehr.org.
Ole WichmannImmunization Unit, Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany. WichmannO@rki.de.ORCID 0000-0003-2353-7188
Doris AltmannInfectious Disease Data Science Unit, Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany. AltmannD@rki.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We reviewed tick-borne encephalitis (TBE) surveillance and epidemiology in Germany, as these underlie public health recommendations, foremost vaccination. We performed descriptive analyses of notification data (2001⁻2018, n = 6063) according to region, demographics and clinical manifestations and calculated incidence trends using negative binomial regression. Risk areas were defined based on incidence in administrative districts. Most cases (89%) occurred in the federal states of Baden-Wurttemberg and Bavaria, where annual TBE incidence fluctuated markedly between 0.7⁻2.0 cases/100,000 inhabitants. A slight but significantly increasing temporal trend was observed from 2001⁻2018 (age-adjusted incidence rate ratio (IRR) 1.02 (95% confidence interval (CI): 1.01⁻1.04)), primarily driven by high case numbers in 2017⁻2018. Mean incidence was highest in 40⁻69-year-olds and in males. More males (23.7%) than females (18.0%,

Indexed as

clinical manifestationsepidemiologyGermanyincidencerisk areastemporospatial distributionTick-borne encephalitis (TBE)vaccination

Identifiers

PMID30934855
PMCPMC6630332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.